CLINICAL TRIALS PROFILE FOR BIMATOPROST
✉ Email this page to a colleague
505(b)(2) Clinical Trials for BIMATOPROST
| Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|---|
| OTC | NCT01325337 ↗ | Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia | Completed | Allergan | Phase 2 | 2011-06-01 | This study will evaluate the safety and efficacy of 3 doses of bimatoprost solution compared with vehicle and over-the-counter (OTC) minoxidil 5% solution in men with androgenic alopecia. All treatments will be provided in a double-blinded fashion except for minoxidil 5% solution which will be provided open-label. |
| OTC | NCT01325350 ↗ | Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss | Completed | Allergan | Phase 2 | 2011-06-01 | This study will evaluate the safety and efficacy of 3 doses of bimatoprost solution compared with vehicle and over-the-counter (OTC) minoxidil 2% solution in women with female pattern hair loss. All treatments will be provided in a double-blinded fashion except for minoxidil 2% solution which will be provided open-label. |
| New Formulation | NCT01426113 ↗ | A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma | Terminated | Allergan | Phase 3 | 2011-09-01 | The purpose of this study is to assess the safety and efficacy of a new formulation of bimatoprost ophthalmic solution compared to timolol ophthalmic solution in the treatment of paediatric patients with glaucoma. |
| >Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for BIMATOPROST
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00187577 ↗ | Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata | Completed | University of California, San Francisco | N/A | 2005-06-01 | This is a single center, randomized, investigator-masked study to determine the efficacy and safety of latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients who have lost their eyelashes due to alopecia areata. These medications are FDA-approved as eyedrops for patients with glaucoma who have been noted to grow longer, darker, and thicker eyelashes with their use. In this study, patients will be asked to apply these solutions to the affected eyelid margins of one eye with a sterile cotton-tipped applicator once a day. |
| NCT00273455 ↗ | Lumigan Versus Cosopt | Completed | Pharmaceutical Research Network | Phase 4 | 2006-01-01 | To compare the intraocular pressure effect and safety of the dorzolamide/timolol fixed combination given twice daily versus bimatoprost given once every evening in patients with open-angle glaucoma in patients insufficiently controlled on latanoprost monotherapy |
| NCT00300443 ↗ | Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension | Completed | Allergan | Phase 2/Phase 3 | 2005-12-01 | The purpose of this study is to assess the safety and efficacy of bimatoprost in patients with glaucoma or ocular hypertension |
| NCT00332059 ↗ | Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension | Completed | Allergan | Phase 3 | 2003-05-01 | The purpose of this study is to assess the safety and efficacy of Bimatoprost/Timolol Fixed Combination in patients with glaucoma or ocular hypertension |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BIMATOPROST
Condition Name
Clinical Trial Locations for BIMATOPROST
Trials by Country
Clinical Trial Progress for BIMATOPROST
Clinical Trial Phase
Clinical Trial Sponsors for BIMATOPROST
Sponsor Name
